Consecutive renal biopsy in a cohort of patients with lupus nephritis of the Colombian Caribbean
| dc.contributor.author | Aroca-Martínez, Gustavo J. | |
| dc.contributor.author | Mendoza-Jaimes, Jackeline | |
| dc.contributor.author | Gonzalez-Torres, Henry J. | |
| dc.contributor.author | Dominguez-Vargas, Alex | |
| dc.contributor.author | Martinez-Bayona, Álvaro | |
| dc.contributor.author | Navarro-Quiroz, Elkin | |
| dc.contributor.author | García-Tolosa, Raúl | |
| dc.contributor.author | Castillo-Parodi, Luis | |
| dc.contributor.author | Carlos G., Musso | |
| dc.contributor.author | Cadena-Bonfanti, Andrés | |
| dc.date.accessioned | 2018-08-29T19:01:23Z | |
| dc.date.available | 2018-08-29T19:01:23Z | |
| dc.date.issued | 2018 | |
| dc.description.abstract | Background: Renal biopsy is the gold standard for the diagnosis and classification of lupus nephritis (LN). However, a consecutive biopsy can predict the clinical course and optimize the therapeutic strategies. Objectives: To compare the histopathological findings with clinical responses. Patients and Methods: Thirty patients with active LN were included. Renal biopsies were performed at the time of diagnosis and subsequently under clinical criteria according to consensus of Spanish Society of Nephrology. The response to treatment was defined as complete response, partial responder or non-responder. The histological change in second biopsy towards LN classes I, II or III/IV-C was defined as histological response (HR). Results: In initial renal biopsy, 28 (93%) patients showed proliferative LN; III-A or A/C (n; 7), IV-A or A/C (n: 19) and mixed; III+IV/V (n; 2). LN class V was presented in two cases. The clinical response was; complete response (10%), partial response (20%), and non-response (70%). HR was manifested in 37% and non-histologic response in 63% of patients. Around 33% of patients with complete response/partial response showed active lesions in the consecutive renal biopsy. Conclusions: In Colombian Caribbean, LN is aggressive and refractory to treatment. The consecutive renal biopsy allowed to demonstrate the persistence of the activity of the lesion in almost half of the patients, which may provide additional information to create better response criteria. The consecutive renal biopsy is a tool that allows improving the evaluation of the response to treatment in the LN. | eng |
| dc.identifier.issn | 22518363 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12442/2235 | |
| dc.language.iso | eng | eng |
| dc.publisher | Society of Diabetic Nephropathy Prevention | eng |
| dc.rights.accessrights | info:eu-repo/semantics/openAccess | |
| dc.rights.license | Licencia de Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacional | spa |
| dc.source | Journal of Nephropathology | eng |
| dc.source | Vol. 7, No.4 (2018) | spa |
| dc.source.uri | http://www.nephropathol.com/PDF/jnp-7-233.pdf | eng |
| dc.subject | Lupus nephritis | eng |
| dc.subject | Renal biopsy | eng |
| dc.subject | Clinical response | eng |
| dc.subject | Consecutive renal biopsy | eng |
| dc.title | Consecutive renal biopsy in a cohort of patients with lupus nephritis of the Colombian Caribbean | eng |
| dc.type | article | eng |
| dcterms.references | Pinto Peñaranda LF, Castro Mercado IL, Duque Caballero V, Márquez Hernández JD, Velásquez Franco CJ. Factores de riesgo predictores de falla a la terapia de inducción de nefritis lúpica en una cohorte de pacientes colombianos. Reumatol Clin. 2014;10(3):147-151. doi:10.1016/j. reuma.2013.09.005. | spa |
| dcterms.references | Peñaranda LFP. Nefropatía lúpica. Rev Colomb Nefrol. 2014;2(1):104-17. | spa |
| dcterms.references | D’Cruz DP, Khamashta MA, Hughes GR. Systemic lupus erythematosus. Lancet. 2007;369(9561):587-96. doi:10.1016/S0140-6736(07)60279-7. | eng |
| dcterms.references | González Naranjo LA, Vásquez Duque GM, Uribe Uribe O, Ramírez Gómez LA. Nefropatía lúpica. Nefropatía lúpica. Presentación clínica, clasificación y tratamiento. Rev Colomb Reumatol. 2006;13(4):307-33. | spa |
| dcterms.references | Lightstone L. Lupus nephritis: where are we now? Curr Opin Rheumatol. 2010;22(3):252-6. doi:10.1097/ BOR.0b013e3283386512. | eng |
| dcterms.references | Restrepo-Escobar M, Granda-Carvajal PA, Jaimes F. Systematic review of the literature on reproducibility of the interpretation of renal biopsy in lupus nephritis. Lupus. 2017;26(14):1502-12. doi:10.1177/0961203317706556. | eng |
| dcterms.references | Zickert A, Sundelin B, Svenungsson E, Gunnarsson I. Role of early repeated renal biopsies in lupus nephritis. Lupus Sci Med. 2014;1(1):e000018. doi:10.1136/ lupus-2014-000018. | eng |
| dcterms.references | Hill G, Delahousse M, Nochy D, Rémy P, Mignon F, Méry JP, et al. Predictive power of second renal biopsy in lupus nephritis: Siginficance of macrophages. Kidney Int. 2001;59(1):304-16. | eng |
| dcterms.references | Hill GS, Delahousse M, Nochy D, Tomkiewicz E, Rémy P, Mignon F, et al. A new morphologic index for the evaluation of renal biopsies in lupus nephritis. Kidney Int. 2000;58(3):1160-73. doi:10.1046/j.1523- 1755.2000.00272.x. | eng |
| dcterms.references | Aroca-Martínez G, Depine S, Consuegra-Machado JR, González-Torres HJ, Árquez-Mendoza M, Estrada- García E. Development and use of an application programming interface modified from GoogleMaps© for the georeferencing of patients with glomerular disease. Nefrologia. 2015;35(1):118-20. doi:10.3265/Nefrologia. pre2014.Oct.12736. | spa |
| dcterms.references | Hahn BH, McMahon MA, Wilkinson A, Wallace WD, Daikh DI, Fitzgerald JD, et al. American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis. Arthritis Care Res (Hoboken). 2012;64(6):797-808. doi:10.1002/acr.21664. | eng |
| dcterms.references | Ruiz Irastorza G, Espinosa G, Frutos MA, Jiménez Alonso J, Praga M, Pallarés L, et al. Diagnosis and treatment of Lupus nephritis: Consensus document from the systemic auto-immune disease group (GEAS) of the Spanish society of internal medicine (SEMI) and the Spanish society of nephrology (S.E.N.). Nefrologia. 2012;32(Suppl 1):1-35. doi:10.3265/Nefrologia.pre2011. Dec.11298. | eng |
| dcterms.references | Gorostidi M, Santamaría R, Alcázar R, Fernández- Fresnedo G, Galcerán JM, Goicoechea M, et al. Spanish Society of Nephrology document on KDIGO guidelines for the assessment and treatment of chronic kidney disease. Nefrologia. 2014;34(3):302-16. doi:10.3265/ Nefrologia.pre2014.Feb.12464. | eng |
| dcterms.references | Weening JJ, D’Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int. 2004;65(2):521-30. doi:10.1111/ j.1523-1755.2004.00443.x. | eng |
| dcterms.references | O’Donnell JK, Tobey M, Weiner DE, Stevens LA, Johnson S, Stringham P, et al. Prevalence of and risk factors for chronic kidney disease in rural Nicaragua. Nephrol Dial Transpl. 2011;26(9):2798-805. doi:10.1093/ndt/gfq385. | eng |
| dcterms.references | Gil M, Jiménez CA, Arias LF. Segunda biopsia renal en nefritis lúpica: Cambios histopatológicos. Rev Esp Patol. 2012;45(3):157-62. doi:10.1016/j.patol.2012.03.005. | spa |
| dcterms.references | Malvar A, Pirruccio P, Alberton V, Lococo B, Recalde C, Fazini B, et al. Histologic versus clinical remission in proliferative lupus nephritis. Nephrol Dial Transplant. 2017;32(8):1338-44. doi:10.1093/ndt/gfv296. | eng |
| dcterms.references | Alsuwaida A, Husain S, Alghonaim M, AlOudah N, Alwakeel J, ullah A, et al. Strategy for second kidney biopsy in patients with lupus nephritis. Nephrol Dial Transplant. 2012;27(4):1472-8. doi:10.1093/ndt/gfr517. | eng |
| dcterms.references | Moroni G, Pasquali S, Quaglini S, Banfi G, Casanova S, Maccario M, et al. Clinical and prognostic value of serial renal biopsies in lupus nephritis. Am J Kidney Dis. 1999;34(3):530-9. doi:10.1053/AJKD03400530. | eng |
| dcterms.references | Kopetschke K, Klocke J, Grießbach AS, Humrich JY, Biesen R, Dragun D, et al. The cellular signature of urinary immune cells in Lupus nephritis: new insights into potential biomarkers. Arthritis Res Ther. 2015;17:94. doi:10.1186/s13075-015-0600-y. | eng |
| dcterms.references | Gunnarsson I, Sundelin B, Heimbürger M, Forslid J, van Vollenhoven R, Lundberg I, et al. Repeated renal biopsy in proliferative lupus nephritis--predictive role of serum C1q and albuminuria. J Rheumatol. 2002;29(4):693-9. | eng |
| dcterms.references | Alba P, Bento L, Cuadrado MJ, Karim Y, Tungekar MF, Abbs I, et al. Anti-dsDNA, anti-Sm antibodies, and the lupus anticoagulant: significant factors associated with lupus nephritis. Ann Rheum Dis. 2003;62(6):556-60. doi:10.1136/ard.62.6.556 | eng |
| dcterms.references | Anaya JM, Cañas C, Mantilla RD, Pineda-Tamayo R, Tobón GJ, Herrera-Diaz C, et al. Lupus nephritis in Colombians: contrasts and comparisons with other populations. Clin Rev Allergy Immunol. 2011;40(3):199- 207. doi:10.1007/s12016-010-8249-4. | eng |
| dcterms.references | Dolff S, Abdulahad WH, Arends S, van Dijk MC, Limburg PC, Kallenberg CG, et al. Urinary CD8+ T-cell counts discriminate between active and inactive lupus nephritis. Arthritis Res Ther. 2013;15(1):R36. doi:10.1186/ar4189. | eng |
| dcterms.references | Abdulahad WH, Kallenberg CGM, Limburg PC, Stegeman CA. Urinary CD4+ effector memory T cells reflect renal disease activity in antineutrophil cytoplasmic antibodyassociated vasculitis. Arthritis Rheum. 2009;60(9):2830-8. doi: 10.1002/art.24747. | eng |
| dcterms.references | Burgos PI, McGwin G Jr, Pons-Estel GJ, Reveille JD, Alarcón GS, Vilá LM. US patients of Hispanic and African ancestry develop lupus nephritis early in the disease course: data from LUMINA, a multiethnic US cohort (LUMINA LXXIV). Ann Rheum Dis. 2011;70(2):393-4. doi:10.1136/ard.2010.131482. | eng |
| dcterms.references | García OB, Algarín RL, Fonseca LMS, Martínez GA. Factores Predictores de Respuesta a Tratamiento de Nefritis Lúpica en Pacientes Adultos Biopsiados en la Clínica de la Costa de Barranquilla ( Atlántico-Colombia ) durante el período 2008-2014 Predictors of Response to Treatment of Nephritis Adults in lup. Biociencias. 2015;10(2):107-17. | eng |
| dcterms.references | Arroyo A, García R, Aroca G, Acosta J. Correlación clínica e inmunohistopatológica de la nefropatía lúpica en un centro de referencia del Caribe colombiano durante los años 2012 a 2013. Rev Colomb Nefrol. 2014;1(2):57-64. | spa |
| sb.programa | Especialización en Nefrología | spa |
| sb.sede | Sede Barranquilla | spa |